JCI Q2 Beats, Orders Surge 30%, but Rich Valuation Limits Upside

What happened

Johnson Controls reported strong Q2 results, with total sales up 8% and organic sales up 6%, while adjusted EPS of $1.19 beat expectations. Orders surged 30% organically year-over-year, and backlog reached a record $20.0 billion, up 26% organically, prompting management to raise FY26 guidance. However, the stock already trades at a premium ~41x trailing EPS, reflecting optimistic assumptions for sustained mid-single-digit growth and margin expansion. The impressive backlog and order growth validate near-term demand from data centers and mission-critical projects, but risks from AI capex moderation, APAC weakness, and backlog conversion timing remain. At current valuations, the risk/reward is skewed to the downside, with the base case offering only modest upside versus 20-25% potential drawdown.

Implication

While Q2 results confirm robust demand and momentum in data-center and infrastructure verticals, the stock's elevated multiple leaves little room for error. Investors should consider taking partial profits near current levels and await a wider margin of safety, such as a pullback to the $95-100 range, before building or adding positions. The thesis hinges on sustained high conversion of the record backlog and continued margin expansion; any disappointment could trigger a sharp re-rating.

Thesis delta

The robust Q2 order growth and backlog expansion reinforce the bull case of strong data-center demand, but they do not change the fundamental concern that current valuations already discount years of perfect execution. The report's base-case fair value of $115 is only ~2% above the current price, while downside to $90 represents ~20% risk, making the risk/reward still unfavorable. The key shift is that while near-term momentum has improved, the margin of safety has not, and the thesis remains a potential sell with limited upside.